Market cap
$6.579 B
$100.79 -0.35%
Close of 6 Nov 2026
As of 6 Nov 2026, Lantheus (LNTH) has a market capitalization of $6.58B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.
Revenue
$1.54B
#1270 by revenue
Earnings
$233.6M
#929 by earnings
Shares outstanding
65,401,413
Latest filing cover page
P/E ratio
28.2
Cap ÷ net income
Biotechnology: In Vitro & In Vivo Diagnostic Substances, ranked by market cap
All 19 →- #1Idexx LaboratoriesIDXX$52.9B
- #2LantheusLNTH$6.58B
- #3Oruka TherapeuticsORKA$6.36B
- #4NeogenNEOG$2.54B
- #5Celldex TherapeuticsCLDX$2.22B
What if Lantheus were worth as much as…
Open the what-if tool →Where these numbers come from
Share counts and financials for Lantheus are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.